In addition, the company has completed the relocation of its headquarters to 19204 North Creek Parkway, Suite 100 Bothell, Washington. The facility includes approximately 20,500sqft of R&D facilities and administrative offices.
Scolr has previously entered into a lease termination agreement for its corporate facility providing for the company to receive a total payment of $4.1 million.
Daniel Wilds, president and CEO of Scolr Pharma, said: “We are very pleased to have completed this relocation and the fulfillment of our obligations under the lease termination agreement. Our new facility, formerly occupied by a pharmaceutical company, is ideally suited for both our current and anticipated needs.”